Notes archive.
BFL Asset Finvest's FY26 loss of ₹557.66 lakh confirms prior disclosure
Audited results show reserves wiped out from ₹579.78 lakh to ₹22.12 lakh, but the numbers were already out. A routine filing for a nano-cap under stress.
NCC Blue Water's FY26 results: Zero revenue, auditor flags going concern
The nano-cap posted net profit of ₹285.20 lakhs entirely from land sales as operating income stayed at zero. The auditor says the company's viability is in doubt.
Trejhara profit triples to ₹1,502 lakhs on exceptional gain
Standalone net profit jumps to ₹1,502 lakhs driven by impaired investment recovery; auditor flags going concern at Auroscient subsidiary.
Z-Tech scales back park target, gives FY27 revenue guidance
The concall reveals a retreat from earlier ambitious plans, but the company forecasts 250-260 cr revenue and a cash-flow-positive milestone by March 2027.
Apollo Hospitals maps 1,400-bed expansion and digital break-even timeline
Concall highlights include margin drag from new beds and a path to digital profitability; management offers rare forward guidance on both growth and near-term costs.
Sudeep Pharma FY26: Revenue up 28%, PAT at ₹174 cr
Speciality ingredients segment drives strong performance; company recommends ₹1.50 per share final dividend.
DCM Shriram International posts loss on ₹20.82 cr demerger stamp duty
Annual results show net loss as stamp duty on demerger scheme weighs; board recommends 20% final dividend.
Happy Forgings' FY26 profit jumps 31% as growth remains steady
Annual numbers were largely anticipated after quarterly cues. The bigger news is a ₹50 crore solar expansion that nudges green capex to ₹170 crore.
Juniper Hotels doubles PAT to ₹142 Cr in FY26
Total income rose 10% to ₹1,069 Cr, EBITDA up 21% to ₹444 Cr. But the market had already priced in the strong numbers.
CARE Ratings transcript adds nothing to what was already known
The full transcript of the May 14 Q4/FY26 call covers the same record PAT and 18% revenue growth reported earlier, with no fresh guidance or surprises.
Anantam Highways Trust to double assets with ₹4,700 cr deal, but DPU language softens
Management commits to ₹2.50 quarterly DPU floor, but now says the mega acquisition 'will not go down' rather than being 'accretive' — a subtle yet telling shift. Dividends also become fully taxable.
Refex Renewables net worth turns negative; auditor flags going concern doubts
Auditor raises material uncertainty as standalone net worth slips to negative ₹6,469 lakh; one subsidiary on liquidation basis.
GMM Pfaudler appoints new CEO as German restructuring costs ₹65 cr
Revenue rose 10% and profit 9% in FY26, but exceptional charges from a German workforce cut pulled earnings lower. Gregory Gelhaus takes the helm.
Swastika Castal caps expansion, sees FY26 as inflection year
MD expresses strong confidence; major customers booked 5+ years ahead; new export customers added.
Polymechplast profit triples to ₹2.88 cr on property sale gain
Net profit surges from ₹0.91 cr to ₹2.88 cr, aided by ₹4.05 cr from asset sale. Board recommends ₹1/share final dividend.
Medi-Caps swings to ₹303.75 lacs loss as revenue halves
Consolidated revenue fell 51% to ₹1,244.85 lacs; standalone swung from profit to loss. Pharma division blames US political instability.
BFL Asset Finvest loses ₹557.66 lakhs, reserves nearly wiped out
The nano-cap company's FY26 results show a net loss of ₹557.66 lakhs against a ₹123.62 lakhs profit last year, with reserves collapsing from ₹579.78 lakhs to ₹22.12 lakhs.
Nykaa Q4 profit quadruples to ₹78 cr, as earlier flagged
The earnings were pre-empted by a business update; only new item is a ₹9.4 cr minority stake buy in Earth Rhythm.
Deep Industries transcript confirms prior call; no new price triggers
The transcript of the May 15 concall adds nothing beyond the earlier summary
Exicom's earnings call transcript confirms known numbers, offers no surprises
Full transcript of May 19 call repeats previously disclosed strong revenue growth and consolidated EBITDA breakeven without incremental material information.
Juniper Hotels crosses ₹1,000 cr revenue in FY26, EBITDA margin at 42%
Net profit nearly doubled, but all figures were already disclosed in the May 21 board meeting. The presentation adds no new material information.
Polychem's profit triples, but nearly all of it came from investments.
Standalone net profit jumped to ₹10.14 cr from ₹3.37 cr, but revenue grew only modestly and other income made up 97% of earnings.
Cochin Malabar's net worth slides to negative ₹210 lakhs, auditor flags going concern
Annual results confirm persistent losses and negative net worth; auditor highlights material uncertainty about the company's ability to continue.
Sudeep Pharma wraps FY26 with 28% revenue growth, 26% PAT jump
Audited annual numbers confirm strong speciality ingredients demand and NSS Ireland contribution; final dividend of ₹1.50 per share recommended.
Cosmo First sets 70% specialty revenue target, pivots Zigly to subsidiary
Management sets ROCE target of 14-15% for FY27, expects net debt below 2x EBITDA. Zigly moves from demerger to external capital raise.